Insilico Medicine and Servier Forge US$888 Million Oncology Partnership to Advance AI-Led Drug Discovery
Insilico Medicine has entered into a multi-year strategic collaboration with Servier, valued at up to US$888 million, aimed at accelerating […]
ARTIFICIAL-INTELLIGENCE-IN-DRUG-DEVELOPMENT
